Oxaliplatin Added to Fluoropyrimidine/Bevacizumab as Initial Therapy for Unresectable Metastatic Colorectal Cancer in Older Patients: A Multicenter, Randomized, Open-Label Phase III Trial (JCOG1018)

No benefit of adding OX to FP + BEV as first-line treatment was demonstrated in older patients with MCRC. FP + BEV is recommended for this population.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Oncology
Published
2024-08-26
DOI
https://doi.org/10.1200/jco.23.02722
Citations
12
Primary Topic
Colorectal Cancer Treatments and Studies
Type
article
Field-Weighted Citation Impact
3.39
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Oxaliplatin Added to Fluoropyrimidine/Bevacizumab as Initial Therapy for Unresectable Metastatic Colorectal Cancer in Older Patients: A Multicenter, Randomized, Open-Label Phase III Trial (JCOG1018)

Hiroshi G. Katayama, S Hasegawa, Hitoshi Ojima, Yukihide Kanemitsu et al.
12 citations
Journal of Clinical Oncology
Colorectal Cancer Treatments and Studies
3.39
article

Oxaliplatin Added to Fluoropyrimidine/Bevacizumab as Initial Therapy for Unresectable Metastatic Colorectal Cancer in Older Patients: A Multicenter, Randomized, Open-Label Phase III Trial (JCOG1018)

Hiroshi G. Katayama, S Hasegawa, Hitoshi Ojima, Yukihide Kanemitsu, Atsuo Takashima, Haruhiko Fukuda, Masako Asayama, Jun Watanabe, Toshiki Masuishi, Fumio Nagashima, Junki Mizusawa, Shunsuke Tsukamoto, Tadamichi Denda, Tetsuya Hamaguchi, Masahiko Ando, Ken Nakata, Yasuhiro Shimada, Hideo Baba, Kenichi Nakamura, Katsunori Shinozaki
article en
12 citations

Abstract

No benefit of adding OX to FP + BEV as first-line treatment was demonstrated in older patients with MCRC. FP + BEV is recommended for this population.

Journal of Clinical OncologyVol. 42(33)
Kyorin University (JP), Yokohama City University Medical Center (JP), Nagoya University Hospital (JP), Sakai Municipal Hospital (JP), Hiroshima Prefectural Hospital (JP), Chiba Cancer Center (JP), Saitama Cancer Center (JP), Gunma Prefectural Cardiovascular Center (JP), Aichi Cancer Center (JP), Tokyo National Hospital (JP), Saiseikai Ibaraki Hospital (JP), Saitama Medical University (JP), Yokohama City University (JP), Kumamoto University (JP)
Partnerships for the goals, Good health and well-being
Openalex Percentile: Top 6%
Colorectal Cancer Treatments and Studies
3.39
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.